Recently, it has been shown that the use of NLRP3 inhibitors in a mouse model of diet-induced obesity could significantly reduce body weight [128], thus demonstrating the promising potential of targeting NLRP3. This evidence concerns the gene NLRP3 and obesity due to melanocortin 4 receptor deficiency.